COMP <GO>
LEGN vs ABCL // OPERATING MARGIN
Legend Biotech Corporation (NASDAQ) VS. AbCellera Biologics Inc. (NASDAQ) • 15-METRIC TALLY: LEGN 7
— ABCL 2
▲ OPERATING MARGIN LEADER: LEGN
LAST: $21.63 (-3.00%) • MKT CAP: $4.21B
operating-margins
13.90%
LAST: $12.27 (-6.19%) • MKT CAP: $3.97B
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEGN VS. ABCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEGN | ABCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -20.50% | +30.40 | LEGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | -4.11% | +6.32 | LEGN | /fcf-yield <GO> |
| Operating Margin ACTIVE | 13.90% | -60.00% | +73.90 | LEGN | /operating-margins <GO> |
| Net Profit Margin | 10.90% | -60.00% | +70.90 | LEGN | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 160.60% | -150.70 | ABCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 6.60 | -2.86 | ABCL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | LEGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.2 | 49.0 | +10.20 | LEGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.21B | $3.97B | $232.5M | LEGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEGN REV | ABCL REV | LEGN GROSS % | ABCL GROSS % | LEGN FCF | ABCL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $75.1M | — | — | — | -$174.1M |
| FY 2024 | — | $28.8M | — | — | — | -$187.0M |
| FY 2023 | — | $38.0M | — | — | — | -$43.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEGN // BETA 1.04
ABCL // BETA —